Rating History for Dyne Therapeutics (DYN) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for DYN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/2/2026 Michael Freeman Maintain Strong Buy
(N/A)		 40.00
(N/A)		  
 		   Details